Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Cell Biology

Background:

• Endothelial progenitor cells (EPCs) are mobilized from bone marrow and play a role in neovascularization.
• EPCs can prevent cardiomyocyte apoptosis, reduce remodeling, and improve cardiac function in ischemic myocardium.
• Endothelial damage and dysfunction are critical in atherosclerosis, prompting research into EPCs' role in vascular maintenance.

Purpose of the Study:

• To evaluate the role of EPCs in vascular endothelial layer maintenance.
• To explore the therapeutic potential of EPCs in cell-based therapies for ischemic diseases.
• To investigate the prognostic value of EPCs in cardiovascular events.

Main Methods:

• Animal studies confirming EPCs' role in neovascularization.
• Clinical trials investigating autologous bone marrow cell transfer after myocardial infarction.
• Observational studies correlating EPC number and function with atherosclerosis progression and cardiovascular risk factors.

Main Results:

• EPCs demonstrate regenerative capacity, homing, and integration into blood vessels, suggesting a protective role in vascular homeostasis.
• The number and function of EPCs are inversely associated with cardiovascular risk factors and atherosclerosis progression.
• Reduced EPC numbers and function correlate with increased cardiovascular risk.
• Recent studies indicate EPC numbers can predict cardiovascular events.

Conclusions:

• EPCs hold potential for cell-based therapy in ischemic tissues and myocardial infarction.
• EPCs are crucial for vascular homeostasis and their function is impaired in atherosclerosis.
• EPCs represent a novel prognostic biomarker for cardiovascular events.